Skip to content
OpenCapital
Get started

Wave Life Sciences WVE Return on assets

Return on assets at other companies

Eli Lilly logo
Eli LillyLLY
24.5%+10.1pp
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
-7.4%-8.6pp
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-10.4%-2.8pp
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
-27.8%-5.8pp
ALN
Alnylam PharmaceuticalsALNY
10.8%+8.0pp
Beam Therapeutics logo
Beam TherapeuticsBEAM
-33.3%—

Other financials

Income statement

See full
Revenue$38.2M+317%
Operating income-$31.3M+37.2%
Net income-$26.1M+44.4%
EPS (diluted)-$0.13+55.2%

Balance sheet

See full
Cash & equivalents$544.6M+124%
Total debt$15.7M-33.4%
Total equity$511.7M+198%
Total assets$583.5M+102%

Cash flow

See full
Operating cash flow-$59.6M+5.5%
CapEx$438.0K+165%
Free cash flow-$60.0M+5.1%

Valuation

See full
Market cap$1.14B+13.0%
Enterprise value$615.92M-22.3%
P/S15.1×-12.2×

Profitability

See full
Operating margin-75.7%-33.6pp
Net margin-66.5%-29.9pp
FCF margin-27.2%-12.6pp

Returns & leverage

See full
Return on equity-53.7%—
Debt / equity0×-0.1×
Current ratio11.3×+8.3×

Where this comes from

Calculated from Wave Life Sciences’s reported figures.

net income/total assets=-42.1%

Based on trailing twelve months.

The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Wave Life Sciences's return on assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Wave Life Sciences's return on assets?
Wave Life Sciences (WVE) reported return on assets of -42.1% in Q1 2026.
What is the long-term trend for Wave Life Sciences's return on assets?
Over 4 years (2020 to 2025), Wave Life Sciences's return on assets has grown at a -6.2% compound annual growth rate (CAGR), from -53.2% to -41.3%.
What does return on assets mean?
Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.